{"access_restricted": false, "aka": ["http://www.loc.gov/item/usrep410052/", "http://www.loc.gov/resource/usrep.usrep410052/", "http://www.loc.gov/item/usrep.usrep410052/"], "campaigns": [], "contributor": ["supreme court of the united states", "white, byron raymond"], "date": "1972", "dates": ["1972-01-01T00:00:00Z"], "digitized": true, "extract_timestamp": "2021-06-29T13:38:58.515Z", "group": ["usrep103", "us-report"], "hassegments": false, "id": "http://www.loc.gov/item/usrep410052/", "image_url": ["https://tile.loc.gov/storage-services/service/ll/usrep/usrep410/usrep410052/usrep410052.gif#h=150&w=100"], "index": 16373, "item": {"call_number": ["Call Number: KF101", "Series: Intellectual Property Law", "Series: Antitrust Law", "Series: Volume 410"], "contributors": ["White, Byron Raymond (Judge)", "Supreme Court of the United States (Author)"], "created_published": ["1972"], "date": "19720000", "format": "periodical", "genre": ["Periodical"], "language": ["eng"], "notes": ["Description: U.S. Reports Volume 410; October Term, 1972; United States v. Glaxo Group Ltd. et al."], "rights": "no known restrictions on use or reproduction", "source_collection": "U.S. Reports", "subjects": ["Law", "Patents", "Health", "Law Library", "Supreme Court", "United States", "Government Documents", "Judicial review and appeals", "Intellectual property", "Government", "Injunctions", "Manufacturing", "Commerce", "Competition and antitrust", "Prescription drugs", "U.S. Reports", "Common law", "Court opinions", "Judicial decisions", "Court cases", "Court decisions", "Sherman Act", "Restraints of trade", "Unpatentable", "Unpatented", "Patent validity", "Griseofulvin", "Sales restriction", "Dosage form patent", "Reasonable royalty licensing", "Patent pooling", "Cross licensing", "Periodical"], "title": "U.S. Reports: United States v. Glaxo Group Ltd., 410 U.S. 52 (1973)."}, "language": ["english"], "mime_type": ["image/gif", "application/pdf"], "online_format": ["image", "pdf"], "original_format": ["periodical"], "other_title": [], "partof": ["u.s. reports: antitrust law", "u.s. reports: volume 410", "law library of congress", "united states reports (official opinions of the u.s. supreme court)", "u.s. reports: intellectual property law"], "resources": [{"files": 1, "image": "https://tile.loc.gov/storage-services/service/ll/usrep/usrep410/usrep410052/usrep410052.gif", "pdf": "https://tile.loc.gov/storage-services/service/ll/usrep/usrep410/usrep410052/usrep410052.pdf", "url": "https://www.loc.gov/resource/usrep.usrep410052/"}], "shelf_id": "Call Number: KF101 Series: Intellectual Property Law Series: Antitrust Law Series: Volume 410", "subject": ["competition and antitrust", "intellectual property", "patent validity", "supreme court", "united states", "sherman act", "court opinions", "periodical", "cross licensing", "unpatentable", "law", "prescription drugs", "reasonable royalty licensing", "dosage form patent", "patent pooling", "health", "court cases", "judicial decisions", "law library", "injunctions", "intellectual property law", "griseofulvin", "judicial review and appeals", "government", "restraints of trade", "u.s. reports", "manufacturing", "unpatented", "commerce", "court decisions", "government documents", "sales restriction", "common law", "patents", "antitrust law"], "subject_major_case_topic": ["intellectual property law", "antitrust law"], "timestamp": "2021-06-29T13:52:51.252Z", "title": "U.S. Reports: United States v. Glaxo Group Ltd., 410 U.S. 52 (1973).", "type": "legacyzoom", "url": "https://www.loc.gov/item/usrep410052/", "loc_id": "usrep410052"}